Agenus (Formerly known as Antigenics Inc. - New York)

108 articles with Agenus (Formerly known as Antigenics Inc. - New York)

• Antigenics Inc. (New York) Updates Business Strategy, Outlines Timeline For The Analysis Of Its Phase 3 Kidney Cancer Trial; 81 Jobs Cut

  12/7/2005

• First Patient Enrolled In Investigator-Sponsored Phase 1/2 Trial Of Antigenics Inc. (New York)' Oncophage Cancer Vaccine In Glioma

  11/21/2005

• Antigenics Inc. (New York) CFO To Present At Rodman & Renshaw Techvest Seventh Annual Healthcare Conference

  11/3/2005

• Antigenics Inc. (New York) Reports Third Quarter 2005 Financial Results And Recent Highlights

  10/27/2005

• Antigenics Inc. (New York) Begins Phase 1 Trial Of Aroplatin In Solid Tumors And B-Cell Lymphoma

  10/25/2005

• Stressgen Biotechnologies Corporation's European Patent Upheld Against Antigenics' Challenge

  10/20/2005

• Antigenics Inc. (New York) To Report Third Quarter 2005 Financial Results On October 27, 2005; Conference Call To Follow

  10/20/2005

• Antigenics Inc. (AGEN) To Webcast 2004 Annual Shareholders Meeting

  5/19/2004